These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26278889)

  • 1. Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC Trial.
    Greuter T; Lang S; Holler E; Hawkey CJ; Rogler G; Biedermann L;
    Digestion; 2015; 92(2):83-9. PubMed ID: 26278889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.
    Lindsay JO; Allez M; Clark M; Labopin M; Ricart E; Rogler G; Rovira M; Satsangi J; Farge D; Hawkey CJ; ; ;
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):399-406. PubMed ID: 28497755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
    Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies.
    Marafini I; Di Sabatino A; Zorzi F; Monteleone I; Sedda S; Cupi ML; Antenucci C; Biancheri P; Giuffrida P; Di Stefano M; Corazza GR; Pallone F; Monteleone G
    Aliment Pharmacol Ther; 2014 Oct; 40(8):974-81. PubMed ID: 25112824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
    Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.
    Hommes DW; Duijvestein M; Zelinkova Z; Stokkers PC; Ley MH; Stoker J; Voermans C; van Oers MH; Kersten MJ
    J Crohns Colitis; 2011 Dec; 5(6):543-9. PubMed ID: 22115372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.
    Ferrara JL; Harris AC; Greenson JK; Braun TM; Holler E; Teshima T; Levine JE; Choi SW; Huber E; Landfried K; Akashi K; Vander Lugt M; Reddy P; Chin A; Zhang Q; Hanash S; Paczesny S
    Blood; 2011 Dec; 118(25):6702-8. PubMed ID: 21979939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.
    Schaffer T; Schoepfer AM; Seibold F;
    J Crohns Colitis; 2014 Sep; 8(9):1125-32. PubMed ID: 24636141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.
    Nunes T; Etchevers MJ; Sandi MJ; Pinó Donnay S; Grandjean T; Pellisé M; Panés J; Ricart E; Iovanna JL; Dagorn JC; Chamaillard M; Sans M
    PLoS One; 2014; 9(1):e84957. PubMed ID: 24416322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide.
    Solán L; Kwon M; Carbonell D; Dorado N; Balsalobre P; Serrano D; Chicano-Lavilla M; Anguita J; Gayoso J; Díez-Martín JL; Martínez-Laperche C; Buño I
    Front Immunol; 2019; 10():2338. PubMed ID: 31649665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma biomarkers of lower gastrointestinal and liver acute GVHD.
    Harris AC; Ferrara JL; Braun TM; Holler E; Teshima T; Levine JE; Choi SW; Landfried K; Akashi K; Vander Lugt M; Couriel DR; Reddy P; Paczesny S
    Blood; 2012 Mar; 119(12):2960-3. PubMed ID: 22286196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous Haematopoietic Stem Cell Transplantation for Refractory Crohn's Disease: Efficacy in a Single-Centre Cohort.
    López-García A; Rovira M; Jauregui-Amezaga A; Marín P; Barastegui R; Salas A; Ribas V; Feu F; Elizalde JI; Fernández-Avilés F; Martínez C; Gutiérrez G; Rosiñol L; Carreras E; Urbano A; Lozano M; Cid J; Suárez-Lledó M; Masamunt MC; Comas D; Giner A; Gallego M; Alfaro I; Ordás I; Panés J; Ricart E
    J Crohns Colitis; 2017 Oct; 11(10):1161-1168. PubMed ID: 28419282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cells for refractory Crohn's disease.
    DiNicola CA; Zand A; Hommes DW
    Expert Opin Biol Ther; 2017 May; 17(5):555-564. PubMed ID: 28326848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.
    Hawkey CJ; Allez M; Clark MM; Labopin M; Lindsay JO; Ricart E; Rogler G; Rovira M; Satsangi J; Danese S; Russell N; Gribben J; Johnson P; Larghero J; Thieblemont C; Ardizzone S; Dierickx D; Ibatici A; Littlewood T; Onida F; Schanz U; Vermeire S; Colombel JF; Jouet JP; Clark E; Saccardi R; Tyndall A; Travis S; Farge D
    JAMA; 2015 Dec; 314(23):2524-34. PubMed ID: 26670970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have we made progress in the treatment of GVHD?
    Harris AC; Levine JE; Ferrara JL
    Best Pract Res Clin Haematol; 2012 Dec; 25(4):473-8. PubMed ID: 23200544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.